查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1560006

微生物檢測市場報告：2030 年趨勢、預測與競爭分析

Microbiology Testing Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

微生物檢測的趨勢和預測

到 2030 年，全球微生物檢測市場預計將達到 88 億美元，2024 年至 2030 年複合年成長率為 8.7%。市場的主要驅動力是感染疾病負擔的增加和傳染病的爆發、微生物檢測技術的持續進步以及政府和私人對感染疾病研究的資助不斷增加。全球微生物檢測市場前景廣闊，呼吸系統疾病、血液感染疾病、胃腸道疾病、性行為感染、尿道感染感染和牙周疾病市場充滿機會。

  • Lucintel 預測，由於測試量的增加和技術的持續進步，測試設備在預測期內仍將佔據更大的佔有率。
  • 在這個市場中，由於 COVID-19 大流行以及識別和管理其他呼吸系統疾病的需求不斷增加，預計呼吸系統疾病將出現最高成長。
  • 由於先進的醫療設施和主要市場參與企業的存在，預計北美在預測期內將出現最高的成長。

微生物檢測市場新趨勢

微生物檢測市場正在經歷幾個反映技術發展和不斷變化的醫療需求的關鍵趨勢。了解這些趨勢對於市場相關人員至關重要。

  • 自動化和人工智慧整合：微生物學測試中的自動化和人工智慧整合正在興起，提高了測試效率、準確性和吞吐量。人工智慧演算法提高了資料分析和決策的複雜性，從而更快地得出結果並提高可靠性。
  • 分子診斷：人們對 PCR 和 NGS 等分子診斷的興趣與日俱增。兩者對於病原體檢測都具有敏感性和特異性。這些診斷方法變得越來越容易取得，對於早期、準確的疾病診斷至關重要。
  • 就地檢驗：隨著在盡可能短的時間內現場獲得診斷結果的壓力越來越大，對就地檢驗解決方案的需求從未如此強烈。 POC 測試提高了便利性並加速了臨床和遠端決策。
  • 個人化醫療：個人化醫療的趨勢正在透過個人化診斷和治療決策對微生物檢測產生影響。新的測試技術可以實現針對遺傳和微生物特徵的治療策略。
  • 強調感染疾病監測：加強感染疾病監測和監測有助於微生物檢測創新的激增。目前，測試開發工作的重點是那些能夠早期檢測和監測新出現的病原體和抗菌素抗藥性的測試。

因此，這種動態正在突破診斷、患者照護和整體緊迫健康問題的微生物檢測領域的界限。

微生物檢測市場的最新趨勢

微生物檢測市場的最新趨勢表明技術進步和行業實踐取得了重大飛躍。主要進展包括：

  • 採用先進的診斷技術新的診斷平台和技術，例如多重檢測和改進的PCR系統，正在減少分析時間並提高微生物檢測的準確性。
  • 自動化和機器人技術：實驗室的自動化和機器人化簡化了工作流程，減少了人為錯誤，並提高了吞吐量。
  • 監管更新：更新的法律規範和標準將確保各種臨床應用的可靠性和有效性，並為先進微生物測試的開發和檢驗提供動力。
  • 增加研發投資：微生物檢測技術的關鍵因素之一是對研發的大量投資，引進了更先進、更精確的診斷工具。
  • 檢測服務的全球擴張：微生物檢測服務向新興市場的擴張正在促進診斷的獲取，並為全球衛生工作做出貢獻，特別是在疾病高發地區。

這些因素進一步提高了微生物檢測的能力，並提高了其在不同地區和應用中的有效性和可及性。

微生物檢測市場的策略性成長機會

微生物檢測市場為關鍵應用提供了幾個策略性成長機會。識別和利用這些機會將促進市場的進一步成長。

  • 醫療診斷：醫療機構中增加微生物檢測將進一步改善疾病診斷和管理，特別是透過改進的技術提供更好、更快的診斷。
  • 食品安全檢驗：食品安全檢驗領域不斷成長的需求正在創造新的機會。此類測試將徹底改變這一領域，因為微生物測試的先進水平決定了食品的品質和安全性。
  • 環境監測：環境監測被認為越來越需要微生物檢測來檢測水、空氣和土壤中的污染物和病原體。該領域在環境健康領域的成長方面具有巨大的潛力。
  • 製藥業：製藥業正在評估新的微生物測試在藥物開發和品管中的應用。藥品製造領域提供的創新測試解決方案存在成長機會。
  • 動物診斷：獸醫學中擴大採用微生物檢測，為檢測動物疾病和提供更好的治療提供了更多機會，推動了這個不斷成長的市場領域。

這些成長機會以及不斷增加的應用正在影響微生物檢測市場並推動整個產業的創新。

微生物檢測市場推廣因素及挑戰

這些是影響市場的一些技術、經濟和監管因素。了解微生物檢測市場的促進因素和挑戰將有助於了解市場前景。

推動微生物檢測市場的因素如下：

1. 技術進步： 1. 技術進步：PCR 和分子檢測等診斷技術的進步將透過提高檢測的準確性和效率來推動市場。

2. 不斷成長的醫療需求：不斷成長的醫療需求和對感染疾病的認知正在推動對先進微生物檢測解決方案的需求，並有助於市場擴張。

3. 監管支援：支持性法律規範和標準促進新微生物檢測技術的開發和實施，並確保其可靠性和有效性。

4. 增加研發投資：研發方面的大量投資正在推動微生物檢測的創新，並導致先進診斷工具和技術的引入。

5. 全球衛生計劃：全球控制感染疾病和改善公共衛生的努力正在為擴大微生物檢測創造機會，特別是在資源匱乏的新興市場。

微生物檢測市場面臨的挑戰如下。

1. 成本高：先進的微生物檢測技術的採購成本可能非常昂貴。對於許多資源有限的環境和發展中地區來說，成本可能過高。

2. 監理挑戰：法規環境嚴峻，但複雜的核准系統會減緩新技術引進測試市場的速度。

3. 整合到現有系統和工作流程中：許多新興的微生物檢測技術需要與現有系統和工作流程進行複雜的整合，有時需要進行重大調整。

這些市場促進因素和挑戰正在推動微生物檢測市場的成長軌跡、技術進步和其他整體市場動態。

按細分領域進行微生物檢測

該研究包括按產品類型、測試應用、最終用途和地區對全球微生物測試的預測。

國家微生物檢測市場前景

由於新技術、對準確診斷測試的需求不斷增加以及監管變化，全球微生物測試市場正在經歷顯著成長。以下是美國、中國、德國、印度和日本主要市場近期發展的摘要。

  • 美國：美國市場對先進微生物檢測技術（包括 PCR 和次世代定序）的需求不斷增加。對快速診斷解決方案和個人化醫療的關注正在推動測試準確性和速度領域的創新，確保更好的患者治療結果。
  • 中國：中國微生物檢測市場正在快速成長。推動這一市場的其他因素包括政府增加對醫療基礎設施和研究的投資、採用先進的診斷技術以及加強感染疾病控制措施。
  • 德國：德國繼續走在微生物檢測最新創新的前沿，將自動化和人工智慧融入檢測過程中。新的法律規範已經到位，以支援臨床和研究領域先進測試技術的開發和實施。
  • 印度：由於人們對感染疾病的認知不斷提高以及醫療服務的改善，印度的微生物檢測市場正在擴大。此外，經濟實惠的高通量診斷技術提高了可近性，並實現了更有效的疾病檢測和監測。
  • 日本：對分子診斷和生物資訊學的大量投資正在進一步發展日本微生物檢測市場。面對人口老化和新感染風險等挑戰，重點是提高檢測的準確性和速度。

常問問題

Q1.市場規模有多大？

答：到 2030 年，全球微生物檢測市場預計將達到 88 億美元。

Q2.市場成長預測如何？

答：2024 年至 2030 年，全球微生物檢測市場預計將以 8.7% 的複合年成長率成長。

Q3.影響市場成長的關鍵促進因素是什麼？

答：該市場的主要驅動力是感染疾病負擔和傳染病爆發的增加、微生物檢測技術的持續進步以及政府和私人對感染疾病研究的資助不斷增加。

Q4.市場的主要細分市場是什麼？

答：微生物檢測市場前景廣闊，呼吸系統疾病、血液感染疾病、腸胃疾病、性行為感染、尿道感染、牙周疾病市場都有機會。

Q5.市場上主要企業有哪些？

答：微生物檢測的主要企業如下。

  • Bio-Rad Laboratories
  • Abbott Laboratories
  • Becton and Dickinson
  • F. Hoffmann-La Roche
  • Bruker Corporation
  • Hologic Corporation
  • Danaher Corporation
  • Biomerieux
  • Thermo Fisher Scientific
  • Agilent Technologies

Q6.未來最大的細分市場是什麼？

答：Lucintel 預測，由於測試量的增加和技術的持續進步，測試設備在預測期內仍將佔據更大的佔有率。

Q7. 未來五年預計哪個地區的市場最大？

答：由於先進的醫療設施和主要市場參與企業的存在，預計北美在預測期內將出現最高的成長。

Q8. 可以客製化報告嗎？

答：是的，Lucintel 列出了 10% 的客製化服務，無需額外費用。

目錄

第1章執行摘要

第2章全球微生物檢測市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球微生物檢測市場趨勢（2018-2023）與預測（2024-2030）
  • 按產品分類的全球微生物檢測市場
    • 裝置
    • 試劑
  • 按測試類型分類的全球微生物測試市場
    • 細菌
    • 病毒
    • 真菌
  • 按應用分類的全球微生物檢測市場
    • 呼吸系統疾病
    • 血流感染疾病
    • 消化系統疾病
    • 性行為感染傳染病
    • 尿道感染
    • 牙周病
    • 其他
  • 按最終用途分類的全球微生物檢測市場
    • 醫院
    • 診斷中心
    • 學術研究所
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球微生物檢測市場（按地區）
  • 北美微生物檢測市場
  • 歐洲微生物檢測市場
  • 亞太微生物檢測市場
  • 其他地區微生物檢測市場

第5章 競爭分析

  • 產品系列分析
  • 業務整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 按產品分類的全球微生物檢測市場成長機會
    • 按測試類型分類的全球微生物測試市場成長機會
    • 全球微生物檢測市場成長機會（按應用）
    • 按最終用途分類的全球微生物檢測市場成長機會
    • 全球微生物檢測市場按地區成長機會
  • 全球微生物檢測市場的新興趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球微生物檢測市場的能力
    • 全球微生物檢測市場的合併、收購與合資
    • 認證和許可

第7章主要企業概況

  • Bio-Rad Laboratories
  • Abbott Laboratories
  • Becton and Dickinson
  • F. Hoffmann-La Roche
  • Bruker Corporation
  • Hologic Corporation
  • Danaher Corporation
  • Biomerieux
  • Thermo Fisher Scientific
  • Agilent Technologies
簡介目錄

Microbiology Testing Trends and Forecast

The future of the global microbiology testing market looks promising with opportunities in the respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and periodontal diseases markets. The global microbiology testing market is expected to reach an estimated $8.8 billion by 2030 with a CAGR of 8.7% from 2024 to 2030. The major drivers for this market are increasing burden of infectious diseases and outbreak of epidemics, on-going technological advancements in microbiology testing, and growing government as well as private-public funding for research on infectious diseases.

  • Lucintel forecasts that instruments will remain the larger segment over the forecast period due to increasing testing volume and on-going technological advancements.
  • Within this market, respiratory diseases is expected to witness the highest growth due to the covid-19 pandemic and growing requirement to identify and manage other respiratory ailments.
  • North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare facilities and existence of key market players in the region.

Emerging Trends in the Microbiology Testing Market

The Microbiology Testing market is evolving through several key trends that reflect both the development of technology and changes in healthcare needs. Understanding such trends is indispensable for the stakeholders of the market.

  • Automation and AI Integration: Automation and the integration of artificial intelligence into microbiology testing have been on the rise, thus enhancing the efficiency, accuracy, and throughput of testing. AI algorithms enhance the sophistication of data analysis and decision-making, accelerating results and improving reliability.
  • Molecular Diagnosis: There is an increasing interest in molecular diagnosis; these include PCR and NGS. Both are highly sensitive and specific against the detection of pathogens. These diagnostics are becoming increasingly accessible and crucial for early, accurate disease diagnosis
  • Point-of-Care Testing: There has never been a greater need for point-of-care testing solutions with the increasing pressure to have diagnostic results on-site in as little time as possible. POC testing increases convenience and accelerates decision-making clinically and remotely.
  • Personalized Medicine: One trend, personalized medicine, is having its impact felt on microbiology testing by moving diagnostics and therapeutic decisions onto an individualized basis. New testing technologies make therapeutic strategies targeted at the genetic and microbiological profile possible.
  • More Emphasis on Infectious Diseases Surveillance: Increased infectious disease surveillance and monitoring have, therefore, contributed to an upsurge of innovation in microbiology testing. Efforts on test development now focus on those which will enable early detection and monitoring of emergent pathogens and resistance to antimicrobials.

These dynamics, therefore, are pushing the boundaries in the field of Microbiology Testing for diagnostics, patient care, and overall pressing health concerns.

Recent Developments in the Microbiology Testing Market

Recent trends in the Microbiology Testing market indicate giant strides in technological advancement and also industry practices. Key developments include:

  • Wider use of advanced diagnostic technologies: Novel diagnostic platforms and technologies, such as multiplex assays, and improved PCR systems are reducing analysis time and enhancing the accuracy of microbiology testing, thereby aiding the better management of diseases.
  • Automation and Robotics: Automation and robotics in test laboratories have smoothed the workflow, reduced human error, and increased throughputs, which are very important to deal with the high volume of tests efficiently.
  • Regulatory Updates: An updated regulatory framework and standards will further provide a boost to developing and validating advanced microbiology tests by assuring their reliability and effectiveness in various clinical applications.
  • Increased Investment in R&D: Among the major factors contributing to microbiology testing technologies are heavy investments in research and development, which introduced more sophisticated and precise diagnostic tools.
  • Global Expansion of Testing Services: Expansion in microbiology testing services into emerging markets has been facilitating access to diagnostics, thereby helping global health initiatives, especially in areas with high disease prevalence.

These factors are further developing the capabilities of microbiology testing and enhancing the effectiveness and accessibility of the tests for various regions and applications.

Strategic Growth Opportunities for Microbiology Testing Market

There are a few strategic growth opportunities that the Microbiology Testing market presents for key applications. Identification and capitalization on such opportunities will facilitate further growth of the market.

  • Medical Healthcare Diagnostics: Increased microbiology testing in health facilities will further improve the diagnosis and management of diseases, particularly with improved technologies to provide better and quicker diagnoses.
  • Food Safety Testing: New opportunities are emerging with growing demands in the food safety testing segment. Advanced-level microbiology testing is what determines the quality and safety of the food products; therefore, such tests innovate in this field.
  • Environmental Monitoring: Environmental monitoring is considered to show an increased need for microbiology tests to detect contaminants and pathogens in water, air, and soil. This area has immense potential in terms of growth in the field of environmental health.
  • Pharmaceutical Industry: New microbiology tests are being evaluated by the pharmaceutical industry for applications in drug development and quality control. Innovative testing solutions provided in drug manufacturing have opportunities for growth.
  • Veterinary Diagnostics: With the increased adoption of microbiology tests in veterinary medicine, more opportunities to detect diseases and provide better treatments for animals will arise, offering a boost in this growing market segment.

These growth opportunities are influencing the Microbiology Testing market with increasing applications and driving innovation across industries.

Microbiology Testing Market Driver and Challenges

These are some of the technological, economic, and regulatory factors affecting the market. Knowing the drivers and challenges of the Microbiology Testing market helps in understanding the market landscape.

The factors responsible for driving the microbiology testing market include:

1. Advancement of Technology: Diagnosis technologies such as PCR and molecular assays advance, thereby driving the market by increasing test accuracy and efficiency; hence, improving treatment due to better management of diseases and bringing better outcomes for patients.

2. Rising Healthcare Demand: Increasing healthcare needs and awareness of infectious diseases are fueling demand for advanced microbiology testing solutions, contributing to market expansion.

3. Regulatory Support: Supportive regulatory frameworks and standards are facilitating the development and implementation of new microbiology testing technologies, ensuring their reliability and effectiveness.

4. Increased R&D Investment: Significant investments in research and development are driving innovation in microbiology testing, leading to the introduction of advanced diagnostic tools and techniques.

5. Global Health Initiatives: Global efforts toward fighting infectious diseases and improving public health create opportunities for microbiology testing to expand, particularly in resource-poor and emerging markets.

Challenges in the microbiology testing market are:

1. High Costs: Advanced technologies for microbiology testing may be extremely expensive to procure. The cost could be beyond the means of many resource-constrained settings or developing regions.

2. Regulatory Challenges: Although the regulatory environment has been difficult, complex approval systems may delay the introduction of new technologies to the test market.

3. Integration into Existing Systems and Workflows: Most of the emerging microbiology testing technologies will require intricate integrations with existing systems and workflows, sometimes requiring considerable adjustments; hence, it may impact the speed with which they are adopted.

These drivers and challenges drive the Marketplace for Microbiology Testing with regard to growth trajectories, technological advances, and other overall market dynamics.

List of Microbiology Testing Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies microbiology testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the microbiology testing companies profiled in this report include-

  • Bio-Rad Laboratories
  • Abbott Laboratories
  • Becton and Dickinson
  • F. Hoffmann-La Roche
  • Bruker Corporation
  • Hologic Corporation
  • Danaher Corporation
  • Biomerieux
  • Thermo Fisher Scientific
  • Agilent Technologies

Microbiology Testing by Segment

The study includes a forecast for the global microbiology testing by product, test type, application, end use, and region.

Microbiology Testing Market by Product [Analysis by Value from 2018 to 2030]:

  • Instruments
  • Reagents

Microbiology Testing Market by Test Type [Analysis by Value from 2018 to 2030]:

  • Bacterial
  • Viral
  • Fungal

Microbiology Testing Market by Application [Analysis by Value from 2018 to 2030]:

  • Respiratory Diseases
  • Bloodstream Infection
  • Gastrointestinal Diseases
  • Sexually Transmitted Diseases
  • Urinary Tract Infections
  • Periodontal Diseases

Microbiology Testing Market by End Use [Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Diagnostic Centers
  • Academic & Research Institutes
  • Others

Microbiology Testing Market by Region [Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

Country Wise Outlook for the Microbiology Testing Market

The market for Microbiology Testing has seen considerable growth worldwide due to emerging technologies, a growing need for accurate diagnostic testing, and changing regulations. The following provides a synopsis of some of the recent developments in the main markets, which are the United States, China, Germany, India, and Japan.

  • United States: The USA market is observing a high demand for sophisticated microbiology testing technologies comprising PCR and next-generation sequencing. The focus on rapid diagnostic solutions and personalized medicine encourages innovation in the areas of test accuracy and speed, hence assuring better patient outcomes.
  • China: China's microbiology testing market has grown rapidly. Other driving factors for this market are increased government investments in healthcare infrastructure and research, adoption of advanced diagnostic technologies, and enhanced focus on infectious disease control.
  • Germany: Germany has continuously remained at the forefront of the latest innovations in microbiology testing, integrating automation and AI into test processes. New regulatory frameworks are being set up to support the development and implementation of advanced technologies for testing across both clinical and research settings.
  • India: Growing awareness of infectious diseases, along with an increase in healthcare services in India, has enhanced the country's microbiology testing market. In addition, affordable, high-throughput diagnostic technologies have increased accessibility and allowed for greater efficiency in the detection and monitoring of diseases.
  • Japan: With major investments in molecular diagnostics and bioinformatics, Japan's microbiology testing market is being further advanced. There is a focus on increasing the precision and speed of testing amid challenges involving an aging population and new infectious risks.

Features of the Global Microbiology Testing Market

Market Size Estimates: Microbiology testing market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Microbiology testing market size by various segments, such as by product, test type, application, end use, and region in terms of value ($B).

Regional Analysis: Microbiology testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, test types, applications, end uses, and regions for the microbiology testing market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the microbiology testing market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q1. What is the microbiology testing market size?

Answer: The global microbiology testing market is expected to reach an estimated $8.8 billion by 2030.

Q2. What is the growth forecast for microbiology testing market?

Answer: The global microbiology testing market is expected to grow with a CAGR of 8.7% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the microbiology testing market?

Answer: The major drivers for this market are increasing burden of infectious diseases and outbreak of epidemics, on-going technological advancements in microbiology testing, and growing government as well as private-public funding for research on infectious diseases.

Q4. What are the major segments for microbiology testing market?

Answer: The future of the microbiology testing market looks promising with opportunities in the respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, and periodontal diseases markets.

Q5. Who are the key microbiology testing market companies?

Answer: Some of the key microbiology testing companies are as follows:

  • Bio-Rad Laboratories
  • Abbott Laboratories
  • Becton and Dickinson
  • F. Hoffmann-La Roche
  • Bruker Corporation
  • Hologic Corporation
  • Danaher Corporation
  • Biomerieux
  • Thermo Fisher Scientific
  • Agilent Technologies

Q6. Which microbiology testing market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the larger segment over the forecast period due to increasing testing volume and on-going technological advancements.

Q7. In microbiology testing market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to presence of advanced healthcare facilities and existence of key market players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the microbiology testing market by product (instruments and reagents), test type (bacterial, viral, and fungal), application (respiratory diseases, bloodstream infection, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and others), end use (hospitals, diagnostic centers, academic & research institutes, and others ), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
  • Market Report

Table of Contents

1. Executive Summary

2. Global Microbiology Testing Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Microbiology Testing Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Microbiology Testing Market by Product
    • 3.3.1: Instruments
    • 3.3.2: Reagents
  • 3.4: Global Microbiology Testing Market by Test Type
    • 3.4.1: Bacterial
    • 3.4.2: Viral
    • 3.4.3: Fungal
  • 3.5: Global Microbiology Testing Market by Application
    • 3.5.1: Respiratory Diseases
    • 3.5.2: Bloodstream Infection
    • 3.5.3: Gastrointestinal Diseases
    • 3.5.4: Sexually Transmitted Diseases
    • 3.5.5: Urinary Tract Infections
    • 3.5.6: Periodontal Diseases
    • 3.5.7: Others
  • 3.6: Global Microbiology Testing Market by End Use
    • 3.6.1: Hospitals
    • 3.6.2: Diagnostic Centers
    • 3.6.3: Academic & Research Institutes
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Microbiology Testing Market by Region
  • 4.2: North American Microbiology Testing Market
    • 4.2.1: North American Microbiology Testing Market by Product: Instruments and Reagents
    • 4.2.2: North American Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
  • 4.3: European Microbiology Testing Market
    • 4.3.1: European Microbiology Testing Market by Product: Instruments and Reagents
    • 4.3.2: European Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
  • 4.4: APAC Microbiology Testing Market
    • 4.4.1: APAC Microbiology Testing Market by Product: Instruments and Reagents
    • 4.4.2: APAC Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others
  • 4.5: ROW Microbiology Testing Market
    • 4.5.1: ROW Microbiology Testing Market by Product: Instruments and Reagents
    • 4.5.2: ROW Microbiology Testing Market by Application: Respiratory Diseases, Bloodstream Infection, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Microbiology Testing Market by Product
    • 6.1.2: Growth Opportunities for the Global Microbiology Testing Market by Test Type
    • 6.1.3: Growth Opportunities for the Global Microbiology Testing Market by Application
    • 6.1.4: Growth Opportunities for the Global Microbiology Testing Market by End Use
    • 6.1.5: Growth Opportunities for the Global Microbiology Testing Market by Region
  • 6.2: Emerging Trends in the Global Microbiology Testing Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Microbiology Testing Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Microbiology Testing Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Bio-Rad Laboratories
  • 7.2: Abbott Laboratories
  • 7.3: Becton and Dickinson
  • 7.4: F. Hoffmann-La Roche
  • 7.5: Bruker Corporation
  • 7.6: Hologic Corporation
  • 7.7: Danaher Corporation
  • 7.8: Biomerieux
  • 7.9: Thermo Fisher Scientific
  • 7.10: Agilent Technologies